Xerostomia in head and neck malignancy

Oral Oncology

Volumn 46, Issue 6, 2010, Pages 460-463

  Porter, S R ^a   Fedele, S ^a   Habbab, K M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Head and neck; Radiotherapy; Xerostomia

Indexed keywords

AMIFOSTINE; AQUAPORIN 1; CHOLINERGIC RECEPTOR STIMULATING AGENT; PILOCARPINE; SALIVA SUBSTITUTE;

ACINAR CELL; ACUPUNCTURE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; ELECTROSTIMULATION THERAPY; GENE THERAPY; HEAD AND NECK CANCER; HUMAN; HYPERBARIC OXYGEN; INTENSITY MODULATED RADIATION THERAPY; NERVE STIMULATION; NONHUMAN; ORGAN SIZE; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SALIVARY GLAND; SIALOGRAPHY; STEM CELL TRANSPLANTATION; XEROSTOMIA;

CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; QUALITY OF LIFE; RADIATION INJURIES; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; SALIVARY GLANDS; XEROSTOMIA;

EID: 77952741885     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2010.03.008     Document Type: Review

References (61)

1. Dirix P., Nuyts S., and Van den Bogaert W. Radiation-induced xerostomia in patients with head and neck cancer: a literature review. Cancer 107 (2006) 2525-2534
2. Otmani N. Oral and maxillofacial side effects of radiation therapy on children. J Can Dent Assoc 73 (2007) 257-261
3. Rubira C.M., Devides N.J., Ubeda L.T., Bortolucci Jr. A.G., Lauris J.R., Rubira-Bullen I.R., et al. Evaluation of some oral postradiotherapy sequelae in patients treated for head and neck tumors. Braz Oral Res 21 (2007) 272-277
4. Jham B.C., Reis P.M., Miranda E.L., Lopes R.C., Carvalho A.L., Scheper M.A., et al. Oral health status of 207 head and neck cancer patients before, during and after radiotherapy. Clin Oral Invest 12 (2008) 19-24
5. Dirix P., Nuyts S., Vander Poorten V., Delaere P., and Van den Bogaert W. The influence of xerostomia after radiotherapy on quality of life: results of a questionnaire in head and neck cancer. Support Care Cancer 16 (2008) 171-179
6. Chambers M.S., Tomsett K.L., Artopoulou I.I., Garden A.S., El-Naggar A.K., Martin J.W., et al. Salivary flow rates measured during radiation therapy in head and neck cancer patients: a pilot study assessing salivary sediment formation. J Prosthet Dent 100 (2008) 142-146
7. Valdez I.H. Radiation-induced salivary dysfunction: clinical course and significance. Spec Care Dentist 11 (1991) 252-255
8. Roesink J.M., Moerland M.A., Battermann J.J., Hordijk G.J., and Terhaard C.H. Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head-and-neck region. Int J Radiat Oncol Biol Phys 51 (2001) 938-946
9. Braam P.M., Roesink J.M., Moerland M.A., Raaijmakers C.P., Schipper M., and Terhaard C.H. Long-term parotid gland function after radiotherapy. Int J Radiat Oncol Biol Phys 62 (2005) 659-664
10. Cerezo L., Martín M., López M., Marín A., and Gómez A. Ipsilateral irradiation for well lateralized carcinomas of the oral cavity and oropharynx: results on tumor control and xerostomia. Radiat Oncol 1 4 (2009) 33
11. Price R.E., Ang K.K., Stephens L.C., and Peters L.J. Effects of continuous hyperfractionated accelerated and conventionally fractionated radiotherapy on the parotid and submandibular salivary glands of rhesus monkeys. Radiother Oncol 34 (1995) 39-46
12. Liu CC, Xia R, Guadagnolo A, Cormier JN, Du XL. Risk of xerostomia in association with the receipt of radiation therapy in older patients with head and neck cancer. Am J Ther 2010;8 [Epub ahead of print].
13. Citrin D., Mansueti J., Likhacheva A., Sciuto L., Albert P.S., Rudy S.F., et al. Long-term outcomes and toxicity of concurrent paclitaxel and radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 74 (2009) 1040-1046
14. Konings A.W., Coppes R.P., and Vissink A. On the mechanism of salivary gland radiosensitivity. Int J Radiat Oncol Biol Phys 62 (2005) 1187-1194
15. Li J., Shan Z., Ou G., Liu X., Zhang C., Baum B.J., et al. Structural and functional characteristics of irradiation damage to parotid glands in the miniature pig. Int J Radiat Oncol Biol Phys 62 (2005) 1510-1516
16. Henriksson R., Fröjd O., Gustafsson H., Johansson S., Yi-Qing C., Franzén L., et al. Increase in mast cells and hyaluronic acid correlates to radiation-induced damage and loss of serous acinar cells in salivary glands: the parotid and submandibular glands differ in radiation sensitivity. Br J Cancer 69 (1994) 320-326
17. Juan C.J., Chen C.Y., Jen Y.M., Liu H.S., Liu Y.J., Hsueh C.J., et al. Perfusion characteristics of late radiation injury of parotid glands: quantitative evaluation with dynamic contrast-enhanced MRI. Eur Radiol 19 (2009) 94-102
18. Astreinidou E., Roesink J.M., Raaijmakers C.P., Bartels L.W., Witkamp T.D., Lagendijk J.J., et al. 3D MR sialography as a tool to investigate radiation-induced xerostomia: feasibility study. Int J Radiat Oncol Biol Phys 68 (2007) 1310-1319
19. Ying M., Wu V.W., and Kwong D.L. Comparison of sonographic appearance of normal and postradiotherapy parotid glands: a preliminary study. Ultrasound Med Biol 33 (2007) 1244-1250
20. Rades D., Stoehr M., Meyners T., Bohlen G., Nadrowitz R., Dunst J., et al. Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer. Strahlenther Onkol 184 (2008) 198-205
21. Voordeckers M., Everaert H., Tournel K., Verellen D., Baron I., Van Esch G., et al. Longitudinal assessment of parotid function in patients receiving tomotherapy for head-and-neck cancer. Strahlenther Onkol 184 (2008) 400-405
22. Eisbruch A. Reducing xerostomia by IMRT: what may, and may not, be achieved. J Clin Oncol 25 (2007) 4863-4864
23. Pow E.H., Kwong D.L., McMillan A.S., Wong M.C., Sham J.S., Leung L.H., et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 66 (2006) 981-991
24. Vergeer M.R., Doornaert P.A., Rietveld D.H., Leemans C.R., Slotman B.J., and Langendijk J.A. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program. Int J Radiat Oncol Biol Phys 74 (2009) 1-8
25. Chen W.C., Hwang T.Z., Wang W.H., Lu C.H., Chen C.C., Chen C.M., et al. Comparison between conventional and intensity-modulated post-operative radiotherapy for stage III and IV oral cavity cancer in terms of treatment results and toxicity. Oral Oncol 45 (2009) 505-510
26. Dijkema T., Terhaard C.H., Roesink J.M., Braam P.M., van Gils C.H., Moerland M.A., et al. Large cohort dose-volume response analysis of parotid gland function after radiotherapy: intensity-modulated versus conventional radiotherapy. Int J Radiat Oncol Biol Phys 72 (2008) 1101-1109
27. Murdoch-Kinch C.A., Kim H.M., Vineberg K.A., Ship J.A., and Eisbruch A. Dose-effect relationships for the submandibular salivary glands and implications for their sparing by intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 72 (2008) 373-382
28. van Luijk P., Faber H., Schippers J.M., Brandenburg S., Langendijk J.A., Meertens H., et al. Bath and shower effects in the rat parotid gland explain increased relative risk of parotid gland dysfunction after intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 74 (2009) 1002-1005
29. van Rij C.M., Oughlane-Heemsbergen W.D., Ackerstaff A.H., Lamers E.A., Balm A.J., and Rasch C.R. Parotid gland sparing IMRT for head and neck cancer improves xerostomia related quality of life. Radiat Oncol 3 (2008) 41
30. Kam M.K., Leung S.F., Zee B., Chau R.M., Suen J.J., Mo F., et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 25 (2007) 4873-4879
31. Marzi S., Iaccarino G., Pasciuti K., Soriani A., Benassi M., Arcangeli G., et al. Analysis of salivary flow and dose-volume modeling of complication incidence in patients with head-and-neck cancer receiving intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 73 (2009) 1252-1259
32. Koukourakis M.I., and Danielidis V. Preventing radiation induced xerostomia. Cancer Treat Rev 31 (2005) 546-554
33. Wasserman T.H., Brizel D.M., Henke M., Monnier A., Eschwege F., Sauer R., et al. Influence of intravenous amifostine on xerostomia, tumor control, and survival after radiotherapy for head-and-neck cancer: 2-year follow-up of a prospective, randomized, phase III trial. Int J Radiat Oncol Biol Phys 63 (2005) 985-990
34. Antonadou D., Pepelassi M., Synodinou M., Puglisi M., and Throuvalas N. Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer. Int J Radiat Oncol Biol Phys 52 (2002) 739-747
35. Buentzel J., Micke O., Adamietz I.A., Monnier A., Glatzel M., and de Vries A. Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: a randomized placebo-controlled phase III study. Int J Radiat Oncol Biol Phys 64 (2006) 684-691
36. Rudat V., Münter M., Rades D., Grötz K.A., Bajrovic A., Haberkorn U., et al. The effect of amifostine or IMRT to preserve the parotid function after radiotherapy of the head and neck region measured by quantitative salivary gland scintigraphy. Radiother Oncol 89 (2008) 71-80
37. Law A., Kennedy T., Pellitteri P., Wood C., Christie D., and Yumen O. Efficacy and safety of subcutaneous amifostine in minimizing radiation-induced toxicities in patients receiving combined-modality treatment for squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 69 (2007) 1361-1368
38. Anné P.R., Machtay M., Rosenthal D.I., Brizel D.M., Morrison W.H., Irwin D.H., et al. A Phase II trial of subcutaneous amifostine and radiation therapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys 67 (2007) 445-452
39. Haddad R., Sonis S., Posner M., Wirth L., Costello R., Braschayko P., et al. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer. Cancer 115 (2009) 4514-4523
40. Simões A, de Campos L, de Souza DN, de Matos JA, Freitas PM, Nicolau J. Laser phototherapy as topical prophylaxis against radiation-induced xerostomia. Photomed Laser Surg 2009 [Epub ahead of print].
41. Jha N., Seikaly H., Harris J., Williams D., Sultanem K., Hier M., et al. Phase III randomized study: oral pilocarpine versus submandibular salivary gland transfer protocol for the management of radiation-induced xerostomia. Head Neck 31 (2009) 234-243
42. Teymoortash A., Müller F., Juricko J., Bieker M., Mandic R., Librizzi D., et al. Botulinum toxin prevents radiotherapy-induced salivary gland damage. Oral Oncol 45 (2009) 737-739
43. Chitra S., and Shyamala Devi C.S. Effects of radiation and alpha-tocopherol on saliva flow rate, amylase activity, total protein and electrolyte levels in oral cavity cancer. Indian J Dent Res 19 (2008) 213-218
44. Shimazu R., Tanaka G., Tomiyama R., Kuratomi Y., and Inokuchi A. Cepharanthin effect on radiation-induced xerostomia and taste disorder in patients with head and neck cancer. Nippon Jibiinkoka Gakkai Kaiho 112 (2009) 648-655
45. Porter S.R., Scully C., and Hegarty A.M. An update of the etiology and management of xerostomia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97 (2004) 28-46
46. Hahnel S., Behr M., Handel G., and Bürgers R. Saliva substitutes for the treatment of radiation-induced xerostomia - a review. Support Care Cancer 17 (2009) 1331-1343
47. Ship J.A., McCutcheon J.A., Spivakovsky S., and Kerr A.R. Safety and effectiveness of topical dry mouth products containing olive oil, betaine, and xylitol in reducing xerostomia for polypharmacy-induced dry mouth. J Oral Rehabil 34 (2007) 724-732
48. Visvanathan V, Nix P. Managing the patient presenting with xerostomia: a review. Int J Clin Pract 2009 [Epub ahead of print].
49. Epstein J.B., Burchell J.L., Emerton S., Le N.D., and Silverman Jr. S. A clinical trial of bethanechol in patients with xerostomia after radiation therapy. A pilot study. Oral Surg Oral Med Oral Pathol 77 (1994) 610-614
50. Joensuu H., Boström P., and Makkonen T. Pilocarpine and carbacholine in treatment of radiation-induced xerostomia. Radiother Oncol 26 (1993) 33-37
51. Chambers M.S., Jones C.U., Biel M.A., Weber R.S., Hodge K.M., Chen Y., et al. Open-label, long-term safety study of cevimeline in the treatment of postirradiation xerostomia. Int J Radiat Oncol Biol Phys 69 (2007) 1369-1376
52. Berk L. Systemic pilocarpine for treatment of xerostomia. Expert Opin Drug Metab Toxicol 4 (2008) 1333-1340
53. Nakamura N., Sasano N., Yamashita H., Igaki H., Shiraishi K., Terahara A., et al. Oral pilocarpine (5 mg t.i.d.) used for xerostomia causes adverse effects in Japanese. Auris Nasus Larynx 36 (2009) 310-313
54. Braga F.P., Sugaya N.N., Hirota S.K., Weinfeld I., Magalhães M.H., and Migliari D.A. The effect of acupuncture on salivary flow rates in patients with radiation-induced xerostomia. Minerva Stomatol 57 (2008) 343-348
55. Cho J.H., Chung W.K., Kang W., Choi S.M., Cho C.K., and Son C.G. Manual acupuncture improved quality of life in cancer patients with radiation-induced xerostomia. J Altern Complement Med 14 (2008) 523-526
56. Garcia M.K., Chiang J.S., Cohen L., Liu M., Palmer J.L., Rosenthal D.I., et al. Acupuncture for radiation-induced xerostomia in patients with cancer: a pilot study. Head Neck 31 (2009) 1360-1368
57. Schiff E., Mogilner J.G., Sella E., Doweck I., Hershko O., Ben-Arye E., et al. Hypnosis for postradiation xerostomia in head and neck cancer patients: a pilot study. J Pain Symptom Manage 37 (2009) 1086-1092
58. Teguh D.N., Levendag P.C., Noever I., Voet P., van der Est H., van Rooij P., et al. Early hyperbaric oxygen therapy for reducing radiotherapy side effects: early results of a randomized trial in oropharyngeal and nasopharyngeal cancer. Int J Radiat Oncol Biol Phys 75 (2009) 711-716
59. Baum BJ, Zheng C, Alevizos I, Cotrim AP, Liu S, McCullagh L, et al. Development of a gene transfer-based treatment for radiation-induced salivary hypofunction. Oral Oncol 2010 [Epub ahead of print].
60. Feng J., van der Zwaag M., Stokman M.A., van Os R., and Coppes R.P. Isolation and characterization of human salivary gland cells for stem cell transplantation to reduce radiation-induced hyposalivation. Radiother Oncol 92 (2009) 466-471
61. Fedele S., Wolff A., Strietzel F., López R.M., Porter S.R., and Konttinen Y.T. Neuroelectrostimulation in treatment of hyposalivation and xerostomia in Sjögren's syndrome: a salivary pacemaker. J Rheumatol 35 (2008) 1489-1494